Prevention of acute kidney injury

Best Practice and Research: Clinical Anaesthesiology

Volumn 31, Issue 3, 2017, Pages 361-370

  Meersch, Melanie ^a   Volmering, Stephanie ^a   Zarbock, Alexander ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

acute kidney injury; biomarkers; KDIGO guidelines; prevention; remote ischemic preconditioning; renal replacement therapy

Indexed keywords

BIOLOGICAL MARKER;

ACUTE KIDNEY FAILURE; DISEASE SEVERITY; GOLD STANDARD; HIGH RISK PATIENT; HOSPITAL MORTALITY; HUMAN; INCIDENCE; ISCHEMIC PRECONDITIONING; MORBIDITY; PERIOPERATIVE PERIOD; PREDICTIVE VALUE; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; REVIEW; RISK REDUCTION; SCORING SYSTEM; ANIMAL; METABOLISM; PROCEDURES; RISK FACTOR;

ACUTE KIDNEY INJURY; ANIMALS; BIOMARKERS; HUMANS; INCIDENCE; ISCHEMIC PRECONDITIONING; PREDICTIVE VALUE OF TESTS; RENAL REPLACEMENT THERAPY; RISK FACTORS;

EID: 85032206383     PISSN: 15216896     EISSN: 1532169X     Source Type: Journal    
DOI: 10.1016/j.bpa.2017.08.002     Document Type: Review

References (99)

1. Uchino, S., Kellum, J.A., Bellomo, R., et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 294:7 (2005), 813–818.
2. Hosohata, K., Role of oxidative stress in drug-induced kidney injury. Int J Mol Sci, 17(11), 2016.
3. Haase, M., Kellum, J.A., Ronco, C., Subclinical AKI – an emerging syndrome with important consequences. Nat Rev Nephrol 8:12 (2012), 735–739.
4. Cerda, J., Lameire, N., Eggers, P., et al. Epidemiology of acute kidney injury. Clin J Am Soc Nephrol 3:3 (2008), 881–886.
5. Ali, T., Khan, I., Simpson, W., et al. Incidence and outcomes in acute kidney injury: a comprehensive population-based study. J Am Soc Nephrol 18:4 (2007), 1292–1298.
6. Wang, H.E., Muntner, P., Chertow, G.M., et al. Acute kidney injury and mortality in hospitalized patients. Am J Nephrol 35:4 (2012), 349–355.
7. Lameire, N.H., Bagga, A., Cruz, D., et al. Acute kidney injury: an increasing global concern. Lancet 382:9887 (2013), 170–179.
8. Mao, H., Katz, N., Ariyanon, W., et al. Cardiac surgery-associated acute kidney injury. Cardiorenal Med 3:3 (2013), 178–199.
9. Romagnoli, S., Zagli, G., Tuccinardi, G., et al. Postoperative acute kidney injury in high-risk patients undergoing major abdominal surgery. J Crit Care 35 (2016), 120–125.
10. Long, T.E., Helgason, D., Helgadottir, S., et al. Acute kidney injury after abdominal surgery: incidence, risk factors, and outcome. Anesth Analg 122:6 (2016), 1912–1920.
11. O'Connor, M.E., Kirwan, C.J., Pearse, R.M., et al. Incidence and associations of acute kidney injury after major abdominal surgery. Intensive Care Med 42:4 (2016), 521–530.
12. Kellum, J.A., Bellomo, R., Ronco, C., Kidney attack. JAMA 307:21 (2012), 2265–2266.
13. Coca, S.G., Singanamala, S., Parikh, C.R., Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int 81:5 (2012), 442–448.
14. Naughton, C.A., Drug-induced nephrotoxicity. Am Fam Physician 78:6 (2008), 743–750.
15. Thakar, C.V., Arrigain, S., Worley, S., et al. A clinical score to predict acute renal failure after cardiac surgery. J Am Soc Nephrol 16:1 (2005), 162–168.
16. Mehta, R.H., Grab, J.D., O'Brien, S.M., et al. Bedside tool for predicting the risk of postoperative dialysis in patients undergoing cardiac surgery. Circulation 114:21 (2006), 2208–2216.
17. Birnie, K., Verheyden, V., Pagano, D., et al. Predictive models for kidney disease: improving global outcomes (KDIGO) defined acute kidney injury in UK cardiac surgery. Crit Care, 18(6), 2014, 606.
18. Schetz, M., Dasta, J., Goldstein, S., et al. Drug-induced acute kidney injury. Curr Opin Crit Care 11:6 (2005), 555–565.
19. McCullough, P.A., Adam, A., Becker, C.R., et al. Risk prediction of contrast-induced nephropathy. Am J Cardiol 98:6A (2006), 27K–36K.
20. Liu, Y., Li, H., Chen, S., et al. Excessively high hydration volume may not be associated with decreased risk of contrast-induced acute kidney injury after percutaneous coronary intervention in patients with renal insufficiency. J Am Heart Assoc, 5(6), 2016.
21. Prasad, A., Ortiz-Lopez, C., Khan, A., et al. Acute kidney injury following peripheral angiography and endovascular therapy: a systematic review of the literature. Catheter Cardiovasc Interv 88:2 (2016), 264–273.
22. Barrett, B.J., Parfrey, P.S., Clinical practice. Preventing nephropathy induced by contrast medium. N Engl J Med 354:4 (2006), 379–386.
23. Kellum, J., Aspelin, P., Barsoum, R.S., et al. KDIGO clinical practice guideline for acute kidney injury 2012. Kidney Int Suppl 2 (2012), 1–138.
24. Del Duca, D., Iqbal, S., Rahme, E., et al. Renal failure after cardiac surgery: timing of cardiac catheterization and other perioperative risk factors. Ann Thorac Surg 84:4 (2007), 1264–1271.
25. Hennessy, S.A., LaPar, D.J., Stukenborg, G.J., et al. Cardiac catheterization within 24 hours of valve surgery is significantly associated with acute renal failure. J Thorac Cardiovasc Surg 140:5 (2010), 1011–1017.
26. Mariscalco, G., Cottini, M., Dominici, C., et al. The effect of timing of cardiac catheterization on acute kidney injury after cardiac surgery is influenced by the type of operation. Int J Cardiol 173:1 (2014), 46–54.
27. Shaz, B.H., Hillyer, C.D., Is there transfusion-related acute renal injury?. Anesthesiology 113:5 (2010), 1012–1013.
28. Cohen, B., Matot, I., Aged erythrocytes: a fine wine or sour grapes?. Br J Anaesth 111:Suppl. 1 (2013), i62–i70.
29. Karkouti, K., Grocott, H.P., Hall, R., et al. Interrelationship of preoperative anemia, intraoperative anemia, and red blood cell transfusion as potentially modifiable risk factors for acute kidney injury in cardiac surgery: a historical multicentre cohort study. Can J Anaesth 62:4 (2015), 377–384.
30. Haase, M., Bellomo, R., Story, D., et al. Effect of mean arterial pressure, haemoglobin and blood transfusion during cardiopulmonary bypass on post-operative acute kidney injury. Nephrol Dial Transpl 27:1 (2012), 153–160.
31. Khan, U.A., Coca, S.G., Hong, K., et al. Blood transfusions are associated with urinary biomarkers of kidney injury in cardiac surgery. J Thorac Cardiovasc Surg 148:2 (2014), 726–732.
32. Kumar, A.B., Suneja, M., Cardiopulmonary bypass-associated acute kidney injury. Anesthesiology 114:4 (2011), 964–970.
33. Thakar, C.V., Yared, J.P., Worley, S., et al. Renal dysfunction and serious infections after open-heart surgery. Kidney Int 64:1 (2003), 239–246.
34. Reents, W., Hilker, M., Borgermann, J., et al. Acute kidney injury after on-pump or off-pump coronary artery bypass grafting in elderly patients. Ann Thorac Surg 98:1 (2014), 9–14 Discussion 14-5.
35. Hynes, C.F., Colo, S., Amdur, R.L., et al. Long-term effects of off-pump coronary bypass versus conventional coronary bypass grafting on renal function. Innovations (Phila) 11:1 (2016), 54–58.
36. Cheungpasitporn, W., Thongprayoon, C., Kittanamongkolchai, W., et al. Comparison of renal outcomes in off-pump versus on-pump coronary artery bypass grafting: a systematic review and meta-analysis of randomized controlled trials. Nephrology, 2015.
37. Schrezenmeier, E.V., Barasch, J., Budde, K., et al. Biomarkers in acute kidney injury – pathophysiological basis and clinical performance. Acta Physiol (Oxf) 219:3 (2017), 554–572.
38. Kashani, K., Cheungpasitporn, W., Ronco, C., Biomarkers of acute kidney injury: the pathway from discovery to clinical adoption. Clin Chem Lab Med 55:8 (2017), 1074–1089.
39. Haase, M., Devarajan, P., Haase-Fielitz, A., et al. The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies. J Am Coll Cardiol 57:17 (2011), 1752–1761.
40. Ronco, C., Kellum, J.A., Haase, M., Subclinical AKI is still AKI. Crit Care, 16(3), 2012, 313.
41. Kashani, K., Al-Khafaji, A., Ardiles, T., et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care, 17(1), 2013, R25.
42. Vanmassenhove, J., Vanholder, R., Nagler, E., et al. Urinary and serum biomarkers for the diagnosis of acute kidney injury: an in-depth review of the literature. Nephrol Dial Transpl 28:2 (2013), 254–273.
43. Mishra, J., Dent, C., Tarabishi, R., et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 365:9466 (2005), 1231–1238.
44. Mishra, J., Ma, Q., Prada, A., et al. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 14:10 (2003), 2534–2543.
45. Mishra, J., Mori, K., Ma, Q., et al. Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol 15:12 (2004), 3073–3082.
46. Devarajan, P., Review: neutrophil gelatinase-associated lipocalin: a troponin-like biomarker for human acute kidney injury. Nephrology 15:4 (2010), 419–428.
47. Parikh, C.R., Devarajan, P., Zappitelli, M., et al. Postoperative biomarkers predict acute kidney injury and poor outcomes after pediatric cardiac surgery. J Am Soc Nephrol 22:9 (2011), 1737–1747.
48. Prowle, J.R., Calzavacca, P., Licari, E., et al. Combination of biomarkers for diagnosis of acute kidney injury after cardiopulmonary bypass. Ren Fail 37:3 (2015), 408–416.
49. Cruz, D.N., Bagshaw, S.M., Maisel, A., et al. Use of biomarkers to assess prognosis and guide management of patients with acute kidney injury. Contrib Nephrol 182 (2013), 45–64.
50. de Geus, H.R., Bakker, J., Lesaffre, E.M., et al. Neutrophil gelatinase-associated lipocalin at ICU admission predicts for acute kidney injury in adult patients. Am J Respir Crit Care Med 183:7 (2011), 907–914.
51. Nickolas, T.L., Schmidt-Ott, K.M., Canetta, P., et al. Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage: a multicenter prospective cohort study. J Am Coll Cardiol 59:3 (2012), 246–255.
52. Nickolas, T.L., O'Rourke, M.J., Yang, J., et al. Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann Intern Med 148:11 (2008), 810–819.
53. Pajek, J., Skoberne, A., Sosteric, K., et al. Non-inferiority of creatinine excretion rate to urinary L-FABP and NGAL as predictors of early renal allograft function. BMC Nephrol, 15, 2014, 117.
54. Pianta, T.J., Peake, P.W., Pickering, J.W., et al. Clusterin in kidney transplantation: novel biomarkers versus serum creatinine for early prediction of delayed graft function. Transplantation 99:1 (2015), 171–179.
55. Flo, T.H., Smith, K.D., Sato, S., et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 432:7019 (2004), 917–921.
56. de Geus, H.R., Ronco, C., Haase, M., et al. The cardiac surgery-associated neutrophil gelatinase-associated lipocalin (CSA-NGAL) score: a potential tool to monitor acute tubular damage. J Thorac Cardiovasc Surg 151:6 (2016), 1476–1481.
57. McIlroy, D.R., Wagener, G., Lee, H.T., Neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery: the effect of baseline renal function on diagnostic performance. Clin J Am Soc Nephrol 5:2 (2010), 211–219.
58. Devarajan, P., Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol 17:6 (2006), 1503–1520.
59. Rodier, F., Campisi, J., Bhaumik, D., Two faces of p53: aging and tumor suppression. Nucleic Acids Res 35:22 (2007), 7475–7484.
60. Witzgall, R., Brown, D., Schwarz, C., et al. Localization of proliferating cell nuclear antigen, vimentin, c-Fos, and clusterin in the postischemic kidney. Evidence for a heterogenous genetic response among nephron segments, and a large pool of mitotically active and dedifferentiated cells. J Clin Invest 93:5 (1994), 2175–2188.
61. Yang, Q.H., Liu, D.W., Long, Y., et al. Acute renal failure during sepsis: potential role of cell cycle regulation. J Infect 58:6 (2009), 459–464.
62. Meersch, M., Schmidt, C., Van Aken, H., et al. Urinary TIMP-2 and IGFBP7 as early biomarkers of acute kidney injury and renal recovery following cardiac surgery. PLoS ONE, 9(3), 2014, e93460.
63. Wetz, A.J., Richardt, E.M., Wand, S., et al. Quantification of urinary TIMP-2 and IGFBP-7: an adequate diagnostic test to predict acute kidney injury after cardiac surgery?. Crit Care, 19, 2015, 3.
64. ∗[IGFBP7] for early prediction of acute kidney injury after coronary artery bypass surgery. Ann Intensive Care, 5(1), 2015, 50.
65. Gocze, I., Koch, M., Renner, P., et al. Urinary biomarkers TIMP-2 and IGFBP7 early predict acute kidney injury after major surgery. PLoS ONE, 10(3), 2015, e0120863.
66. ∗IGFBP7 biomarker panel accurately predicts acute kidney injury in high-risk surgical patients. J Trauma Acute Care Surg 80:2 (2016), 243–249.
67. Koyner, J.L., Shaw, A.D., Chawla, L.S., et al. Tissue inhibitor metalloproteinase-2 (TIMP-2) IGF-binding protein-7 (IGFBP7) levels are associated with adverse long-term outcomes in patients with AKI. J Am Soc Nephrol 26:7 (2015), 1747–1754.
68. Aregger, F., Uehlinger, D.E., Witowski, J., et al. Identification of IGFBP-7 by urinary proteomics as a novel prognostic marker in early acute kidney injury. Kidney Int 85:4 (2014), 909–919.
69. Vijayan, A., Faubel, S., Askenazi, D.J., et al. Clinical use of the urine biomarker [TIMP-2] × [IGFBP7] for acute kidney injury risk assessment. Am J Kidney Dis 68:1 (2016), 19–28.
70. Luo, C., Yuan, D., Yao, W., et al. Dexmedetomidine protects against apoptosis induced by hypoxia/reoxygenation through the inhibition of gap junctions in NRK-52E cells. Life Sci 122 (2015), 72–77.
71. Ji, F., Li, Z., Young, N., et al. Perioperative dexmedetomidine improves mortality in patients undergoing coronary artery bypass surgery. J Cardiothorac Vasc Anesth 28:2 (2014), 267–273.
72. Xue, F.S., Li, R.P., Liu, G.P., et al. Assessing renoprotective effect of perioperative dexmedetomidine in cardiac surgery patients. Kidney Int 89:5 (2016), 1163–1164.
73. Balkanay, O.O., Goksedef, D., Omeroglu, S.N., et al. The dose-related effects of dexmedetomidine on renal functions and serum neutrophil gelatinase-associated lipocalin values after coronary artery bypass grafting: a randomized, triple-blind, placebo-controlled study. Interact Cardiovasc Thorac Surg 20:2 (2015), 209–214.
74. Meersch, M., Schmidt, C., Hoffmeier, A., et al. Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial. Intensive Care Med, 2017.
75. Venkatachalam, M.A., Weinberg, J.M., Kriz, W., et al. Failed tubule recovery, AKI-CKD transition, and kidney disease progression. J Am Soc Nephrol 26:8 (2015), 1765–1776.
76. Zafrani, L., Ince, C., Microcirculation in acute and chronic kidney diseases. Am J Kidney Dis 66:6 (2015), 1083–1094.
77. Matejovic, M., Ince, C., Chawla, L.S., et al. Renal hemodynamics in AKI: in search of new treatment targets. J Am Soc Nephrol 27:1 (2016), 49–58.
78. Walsh, M., Devereaux, P.J., Garg, A.X., et al. Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: toward an empirical definition of hypotension. Anesthesiology 119:3 (2013), 507–515.
79. Magruder, J.T., Dungan, S.P., Grimm, J.C., et al. Nadir oxygen delivery on bypass and hypotension increase acute kidney injury risk after cardiac operations. Ann Thorac Surg 100:5 (2015), 1697–1703.
80. Chuang, C.L., Fluid management in acute kidney injury. Contrib Nephrol 187 (2016), 84–93.
81. Payen, D., de Pont, A.C., Sakr, Y., et al. A positive fluid balance is associated with a worse outcome in patients with acute renal failure. Crit Care, 12(3), 2008, R74.
82. Teixeira, C., Garzotto, F., Piccinni, P., et al. Fluid balance and urine volume are independent predictors of mortality in acute kidney injury. Crit Care, 17(1), 2013, R14.
83. Wu, X., Zhang, W., Ren, H., et al. Diuretics associated acute kidney injury: clinical and pathological analysis. Ren Fail 36:7 (2014), 1051–1055.
84. Bullivant, E.M., Wilcox, C.S., Welch, W.J., Intrarenal vasoconstriction during hyperchloremia: role of thromboxane. Am J Physiol 256:1 Pt 2 (1989), F152–F157.
85. McCluskey, S.A., Karkouti, K., Wijeysundera, D., et al. Hyperchloremia after noncardiac surgery is independently associated with increased morbidity and mortality: a propensity-matched cohort study. Anesth Analg 117:2 (2013), 412–421.
86. Krajewski, M.L., Raghunathan, K., Paluszkiewicz, S.M., et al. Meta-analysis of high- versus low-chloride content in perioperative and critical care fluid resuscitation. Br J Surg 102:1 (2015), 24–36.
87. Kim, J.Y., Joung, K.W., Kim, K.M., et al. Relationship between a perioperative intravenous fluid administration strategy and acute kidney injury following off-pump coronary artery bypass surgery: an observational study. Crit Care, 19, 2015, 350.
88. van den Berghe, G., Wouters, P., Weekers, F., et al. Intensive insulin therapy in critically ill patients. N Engl J Med 345:19 (2001), 1359–1367.
89. Gandhi, G.Y., Nuttall, G.A., Abel, M.D., et al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial. Ann Intern Med 146:4 (2007), 233–243.
90. Bhamidipati, C.M., LaPar, D.J., Stukenborg, G.J., et al. Superiority of moderate control of hyperglycemia to tight control in patients undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 141:2 (2011), 543–551.
91. Przyklenk, K., Bauer, B., Ovize, M., et al. Regional ischemic ‘preconditioning’ protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation 87:3 (1993), 893–899.
92. Zarbock, A., Kellum, J.A., Remote ischemic preconditioning and protection of the kidney – a novel therapeutic option. Crit Care Med 44:3 (2016), 607–616.
93. Zimmerman, R.F., Ezeanuna, P.U., Kane, J.C., et al. Ischemic preconditioning at a remote site prevents acute kidney injury in patients following cardiac surgery. Kidney Int 80:8 (2011), 861–867.
94. Zarbock, A., Schmidt, C., Van Aken, H., et al. Effect of remote ischemic preconditioning on kidney injury among high-risk patients undergoing cardiac surgery: a randomized clinical trial. JAMA 313:21 (2015), 2133–2141.
95. Hausenloy, D.J., Candilio, L., Evans, R., et al. Remote ischemic preconditioning and outcomes of cardiac surgery. N Engl J Med 373:15 (2015), 1408–1417.
96. Meybohm, P., Bein, B., Brosteanu, O., et al. A multicenter trial of remote ischemic preconditioning for heart surgery. N Engl J Med 373:15 (2015), 1397–1407.
97. Liu, Y., Davari-Farid, S., Arora, P., et al. Early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury after cardiac surgery: a systematic review and meta-analysis. J Cardiothorac Vasc Anesth 28:3 (2014), 557–563.
98. Zarbock, A., Kellum, J.A., Schmidt, C., et al. Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: the ELAIN randomized clinical trial. JAMA 315:20 (2016), 2190–2199.
99. Gaudry, S., Hajage, D., Schortgen, F., et al. Initiation strategies for renal-replacement therapy in the intensive care unit. N Engl J Med 375:2 (2016), 122–133.